Fingerprint
Dive into the research topics of 'North Central Cancer Treatment Group N0531: Phase II trial of weekly albumin-bound paclitaxel (ABI-007; Abraxane®) in combination with gemcitabine in patients with metastatic breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically